Breaking News

BioSpectra Launches Contract Manufacturing Services

July 24, 2014

Opens new FDA-registered facility in Bangor, PA

BioSpectra, Inc. has launched contract manufacturing services for pharma and biopharma products from its new FDA-registered facility in Bangor, PA. BioSpectra provides custom cGMP purifications, acidifications, acid/base reactions, custom formulations and particle manipulation, along with documented regulatory support.
“BioSpectra is proud of its customer-focused, custom manufacturing capabilities which provide a unique combination of industry-leading quality – from process chemistry through finished end product,” said Richard Mutchler, president of BioSpectra. “Our clients rest assured knowing they are working with a partner who offers written, declared end-use statements detailing the product is designed, engineered, validated and manufactured solely for the purpose it’s being used. Therefore, we confirm in advance the strict controls with which BioSpectra governs its equipment, processes and products.”

blog comments powered by Disqus
  • CMC Biologics: Growing Through Innovation

    Tim Wright, Editor||January 28, 2016
    The new chief exec talks about industry trends and growth plans.

  • Cold-Chain Logistics & The Central Lab

    Kristin Brooks, Associate Editor||January 28, 2016
    Eric Hayashi of LabConnect discusses safety measures to ensure sample integrity

  • A Look at DCAT Week ‘16

    Tim Wright, Editor||January 28, 2016
    On the pulse of the pharmaceutical manufacturing value chain, DCAT Week ‘16 will deliver top-flight education programs and networking events.